Keyphrases
Cell Survival
100%
Methyltransferase Activity
100%
Histone Methyltransferase
100%
Neuroblastoma Cells
100%
Enhancer of Zeste Homolog 2 (EZH2)
100%
Neuroblastoma
36%
Apoptotic Response
18%
H3K27me3
18%
MYCN Amplification
18%
True Protein
18%
Overall Survival
9%
Cellular Processes
9%
Knockdown
9%
Specific Inhibitor
9%
Cell Cycle Regulation
9%
Lysine
9%
Overexpressing
9%
Methyltransferase
9%
Histone H3
9%
Cellular Differentiation
9%
Chromosome 7
9%
Truncated Forms
9%
Survival Function
9%
Poor Prognosis
9%
Activation Domain
9%
Cyclin D1 (CCND1)
9%
Short Hairpin RNA (shRNA)
9%
Chromosomal Rearrangements
9%
Polycomb Repressive Complex 2 (PRC2)
9%
Catalytic Subunit
9%
Colony Formation
9%
Activity Inhibition
9%
Neuroblastoma Cell Line
9%
GSK126
9%
Isochromosome 17q
9%
Myelocytomatosis Oncogene
9%
G1 Arrest
9%
Prognosis Survival
9%
V-myc
9%
7q36
9%
EPZ6438
9%
17q Gain
9%
Medicine and Dentistry
Cell Survival
100%
Neuroblastoma Cell
100%
Histone Methyltransferase
100%
Transcription Factor EZH2
100%
Ganglioneuroblastoma
27%
Methyltransferase
18%
Malignant Neoplasm
9%
Cell Differentiation
9%
Colony Formation
9%
Overall Survival
9%
Myeloid Leukemia
9%
Cell Cycle Regulation
9%
Enzyme Active Site
9%
Short Hairpin RNA
9%
Chromosome 7
9%
Neuroblastoma Cell Line
9%
Patient with Neuroblastoma
9%
Virus Oncogene
9%
Chromosome 17q
9%
G1/S Transition
9%
Tazemetostat
9%
Cyclin D1
9%
Polycomb Repressive Complex 2
9%
Cell Line
9%
Transactivation
9%
Histone H3
9%
Lysine
9%
Biochemistry, Genetics and Molecular Biology
Cell Survival
100%
Histone Methyltransferase
100%
Transcription Factor EZH2
100%
Complete Protein
18%
Methyltransferase
18%
Wild Type
9%
Transactivation
9%
Chromosomal Rearrangement
9%
Polycomb Repressive Complex 2
9%
Myc
9%
Cellular Differentiation
9%
Cell Cycle Regulation
9%
Enzyme Active Site
9%
Chromosome 7
9%
Overall Survival
9%
Colony Formation
9%
Chromosome 17q
9%
G1/S Transition
9%
Virus Oncogene
9%
Histone H3
9%
Cyclin D1
9%
Small Hairpin RNA
9%
Lysine
9%
Aves
9%